Glucose Monitor Sensor Recall: Abbott Diabetes Care Removes Certain FreeStyle Libre 3 and FreeStyle Libre 3 Plus Sensors

The webinar will feature presentations by Dr. Pippa Curtis-Jackson, Senior Specialist at the Chemical Assessment Unit, UK EA, and Dr. Michelle Embry, Deputy Director of HESI.

CGMP/Finished Pharmaceuticals/Adulterated

Establishment registration and drug listing data is submitted by drug manufacturers and own label drug distributors through electronic means using Structured Product Labeling format (SPL).

Drug Information for Patients and Consumers

The U.S. Food and Drug Administration (FDA) approved Myqorzo (aficamten) tablets to treat adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms.

FDA approves 1st drug for children 7 years and older with irritable bowel syndrome with constipation